Sibille, A. (2023). Eosinophils in non-small cell lung cancer [Doctoral thesis, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/310579 |
Cousin, F., Louis, T., Dheur, S., Aboubakar, F., Ghaye, B., Occhipinti, M., Vos, W., Bottari, F., PAULUS, A., Sibille, A., VAILLANT, F., Duysinx, B., Guiot, J., & Hustinx, R. (25 March 2023). Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers, 15 (7), 1968. doi:10.3390/cancers15071968 Peer Reviewed verified by ORBi |
SIBILLE, A., CORHAY, J.-L., LOUIS, R., Ninane, V., JERUSALEM, G.* , & DUYSINX, B.*. (03 May 2022). Eosinophils and Lung Cancer: From Bench to Bedside. International Journal of Molecular Sciences, 23 (9), 5066. doi:10.3390/ijms23095066 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
ONESTI, C. E., Schroeder, H., Rorive, A., Sautois, B., Lecocq, M., Goffin, M., Gonne, E., Collinge, A., Nicolaers, L., Wéra, O., Catot, A., Loly, C., Paulus, A., Sibille, A., Lousberg, L., Troisfontaine, F., Collignon, J., Gennigens, C., Frères, P., ... Jerusalem, G. (2021). Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study. Cancer Reports, 1571. doi:10.1002/cnr2.1571 Peer reviewed |
Sibille, A., Henket, M., Corhay, J.-L., ALFIERI, R., Louis, R., & Duysinx, B. (October 2021). White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer. Lung, 199 (5), 549-557. doi:10.1007/s00408-021-00474-2 Peer Reviewed verified by ORBi |
Debruche, M., Mettlen, C., PAULUS, A., VAILLANT, F., Sibille, A., Freres, P., Duysinx, B., & Louis, R. (May 2021). Cancer pulmonaire non à petites cellules chez les patients non fumeurs au CHU de Liège : étude rétrospective entre début 2017 et fin 2018. Revue Médicale de Liège, 76 (5-6), 446 - 451. Editorial Reviewed verified by ORBi |
Lambert, N., Steinmetz, M., SIBILLE, A., & SADZOT, B. (2021). Pembrolizumab‐induced migrating cortico‐subcortical brain lesions. Annals of Neurology. doi:10.1002/ana.26054 Peer Reviewed verified by ORBi |
CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044 Peer Reviewed verified by ORBi |
ONESTI, C. E., SCHROEDER, H., RORIVE, A., SAUTOIS, B., LECOCQ, M., Goffin, M., GONNE, E., COLLINGE, A., NICOLAERS, L., WERA, O., Catot, A., LOLY, C., PAULUS, A., SIBILLE, A., LOUSBERG, L., Troisfontaine, F., COLLIGNON, J., GENNIGENS, C., FRERES, P., & JERUSALEM, G. (2020). How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain. |
SIBILLE, A., HENKET, M., Corhay, J.-L., Louis, R., & DUYSINX, B. (2020). Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels [letter to the editor]. Acta Oncologica, 59 (3), 257-259. doi:10.1080/0284186X.2019.1695063 Peer Reviewed verified by ORBi |
SIBILLE, A., Alfieri, R., MALAISE, O., DETREMBLEUR, N., Pirotte, M., Louis, R., & DUYSINX, B. (06 June 2019). Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer. Frontiers in Oncology, 9, 478. doi:10.3389/fonc.2019.00478 Peer Reviewed verified by ORBi |
PELLEGRINI, I., SIBILLE, A., PAULUS, A., VAILLANT, F., Radermecker, M., Corhay, J.-L., Louis, R., & DUYSINX, B. (2019). Comment je traite… Le mésothéliome pleural malin en 2019. Revue Médicale de Liège, 74 (12), 627-632. Peer reviewed |
GESTER, F., PAULUS, A., SIBILLE, A., CORHAY, J.-L., DUYSINX, B., & LOUIS, R. (2016). Facteurs pronostiques du cancer pulmonaire non à petites cellules. Revue Médicale de Liège, 71 (1), 34-39. Peer reviewed |
PAULUS, A., SIBILLE, A., BOURHABA, M., MARTIN, M., LOUIS, R., & DUYSINX, B. (December 2015). PRISE EN CHARGE DES TUMEURS EPITHELIALES THYMIQUES. Revue Médicale de Liège, 70 (12), 623-8. Peer reviewed |
SIBILLE, A., PAULUS, A., MARTIN, M., BOURHABA, M., Barthélemy, N., Radermecker, M., CORHAY, J.-L., LOUIS, R., & DUYSINX, B. (September 2015). PRISE EN CHARGE DU CANCER BRONCHIQUE NON A PETITES CELLULES. Revue Médicale de Liège, 70 (9), 432-41. Peer reviewed |
SIBILLE, A., PAULUS, A., Martin, M., Bourhaba, M., Barthélemy, M., Radermecker, M., Corhay, J.-L., & DUYSINX, B. (September 2015). Prise en charge du cancer bronchique non à petites cellules. Revue Médicale de Liège, 70 (9), 432-441. Peer reviewed |